Portal de Periódicos da CAPES

Synergy Between Human Monoclonal Antibodies to HIV Extends Their Effective Biologic Activity Against Homologous and Divergent Strains

1992; Mary Ann Liebert, Inc.; Volume: 8; Issue: 4 Linguagem: Inglês

10.1089/aid.1992.8.425

1931-8405

Aby Buchbinder, Sylwia Karwowska, Miroslaw K. Górny, Sherri Burda, Susan Zolla‐Pazner,

Monoclonal and Polyclonal Antibodies Research

AIDS Research and Human RetrovirusesVol. 8, No. 4 Synergy Between Human Monoclonal Antibodies to HIV Extends Their Effective Biologic Activity Against Homologous and Divergent StrainsAby Buchbinder, Sylwia Karwowska, Miroslaw K. Gorny, Sherri T. Burda, and Susan Zolla-PaznerAby Buchbinder, Sylwia Karwowska, Miroslaw K. Gorny, Sherri T. Burda, and Susan Zolla-PaznerPublished Online:16 Mar 2009https://doi.org/10.1089/aid.1992.8.425AboutSectionsPDF/EPUB Permissions & CitationsPermissionsDownload CitationsTrack CitationsAdd to favorites Back To Publication ShareShare onFacebookXLinked InRedditEmail FiguresReferencesRelatedDetailsCited byHIV-1 gp41 Residues Modulate CD4-Induced Conformational Changes in the Envelope Glycoprotein and Evolution of a Relaxed Conformation of gp12031 July 2018 | Journal of Virology, Vol. 92, No. 16HIV-1 Vaccine-Induced C1 and V2 Env-Specific Antibodies Synergize for Increased Antiviral ActivitiesJournal of Virology, Vol. 88, No. 14Topological Analysis of HIV-1 Glycoproteins Expressed In Situ on Virus Surfaces Reveals Tighter Packing but Greater Conformational Flexibility than for Soluble gp120Journal of Virology, Vol. 87, No. 16Neutralization Interfering Antibodies: A "Novel" Example of Humoral Immune Dysfunction Facilitating Viral Escape?24 September 2012 | Viruses, Vol. 4, No. 9Env-glycoprotein heterogeneity as a source of apparent synergy and enhanced cooperativity in inhibition of HIV-1 infection by neutralizing antibodies and entry inhibitorsVirology, Vol. 422, No. 1Designing Immunogens for Vaccine Development in Reference to HIV6 June 2011Soluble CD4 broadens neutralization of V3-directed monoclonal antibodies and guinea pig vaccine sera against HIV-1 subtype B and C reference virusesVirology, Vol. 380, No. 2Insensitivity of Paediatric HIV-1 Subtype C Viruses to Broadly Neutralising Monoclonal Antibodies Raised against Subtype B18 July 2006 | PLoS Medicine, Vol. 3, No. 7Expression, purification, and isotope labeling of the Fv of the human HIV-1 neutralizing antibody 447-52D for NMR studiesProtein Expression and Purification, Vol. 29, No. 2Hyperglycosylated Mutants of Human Immunodeficiency Virus (HIV) Type 1 Monomeric gp120 as Novel Antigens for HIV Vaccine DesignJournal of Virology, Vol. 77, No. 10Synergy Determination IssuesJournal of Virology, Vol. 76, No. 20Definition of neutralizing sites on African horse sickness virus serotype 4 VP2 at the level of peptidesJournal of General Virology, Vol. 82, No. 10Additive Effects Characterize the Interaction of Antibodies Involved in Neutralization of the Primary Dualtropic Human Immunodeficiency Virus Type 1 Isolate 89.6Journal of Virology, Vol. 75, No. 19Differential recognition of epitopes present on monomeric and oligomeric forms of gp160 glycoprotein of human immunodeficiency virus type 1 by human monoclonal antibodies20 December 2001 | European Journal of Biochemistry, Vol. 268, No. 10Synergistic Neutralization of Simian-Human Immunodeficiency Virus SHIV-vpu + by Triple and Quadruple Combinations of Human Monoclonal Antibodies and High-Titer Anti-Human Immunodeficiency Virus Type 1 ImmunoglobulinsJournal of Virology, Vol. 72, No. 4Synergistic Neutralization of a Chimeric SIV/HIV Type 1 Virus with Combinations of Human Anti-HIV Type 1 Envelope Monoclonal Antibodies or Hyperimmune Globulins AN LI, TIMOTHY W. BABA, JOSEPH SODROSKI, SUSAN ZOLLA-PAZNER, MIROSLAW K. GORNY, JAMES ROBINSON, MARSHALL R. POSNER, HERMANN KATINGER, CARLOS F. BARBAS, DENNIS R. BURTON, TING-CHAO CHOU, and RUTH M. RUPRECHT15 March 2009 | AIDS Research and Human Retroviruses, Vol. 13, No. 8Synergistic neutralization of human immunodeficiency virus type 1 by a chimpanzee monoclonal antibody against the V2 domain of gp120 in combination with monoclonal antibodies against the V3 loop and the CD4-binding siteJournal of Virology, Vol. 70, No. 7Antibody cross-competition analysis of the human immunodeficiency virus type 1 gp120 exterior envelope glycoproteinJournal of Virology, Vol. 70, No. 3Epitope mapping, V-region DNA sequence, and neutralizing Fab fragments of two monoclonal antibodies against the HIV-1 V3 loopImmunotechnology, Vol. 2, No. 1Human monoclonal antibody 2G12 defines a distinctive neutralization epitope on the gp120 glycoprotein of human immunodeficiency virus type 1Journal of Virology, Vol. 70, No. 2A Resting Cell Assay for Improved Detection of Antibody-Mediated Neutralization of HIV Type 1 Primary Isolates SUSAN ZOLLA-PAZNER and SANDRA SHARPE16 March 2009 | AIDS Research and Human Retroviruses, Vol. 11, No. 12Induction of HIV Type 1 Neutralizing and env-CD4 Blocking Antibodies by Immunization with Genetically Engineered HIV Type 1-Like Particles Containing Unprocessed gp160 Glycoproteins BENJAMIN ROVINSKI, LAUREN RODRIGUES, SHI XIAN CAO, FEI-LONG YAO, URSULA McGUINNESS, CHARLES SIA, GEORGE CATES, SUSAN ZOLLA-PAZNER, SYLWIA KARWOWSKA, THOMAS J. MATTHEWS, CHARLENE B. McDANAL, JOHN MASCOLA, and MICHEL H. KLEIN16 March 2009 | AIDS Research and Human Retroviruses, Vol. 11, No. 10Use of a novel mutagenesis strategy, optimized residue substitution, to decrease the off-rate of an anti-gp120 antibodyMolecular Immunology, Vol. 32, No. 14-15Synergistic inhibition of human immunodeficiency virus type 1 envelope glycoprotein-mediated cell fusion and infection by an antibody to CD4 domain 2 in combination with anti-gp120 antibodiesJournal of Virology, Vol. 69, No. 7Two New Human Monoclonal Antibodies against HIV Type 1 Glycoprotein 120: Characterization and Neutralizing Activities against HIV Type 1 Strains MICHÈLE FÉVRIER, FLORENCE BOUDET, AGNÈS DESLANDRES, and JACQUES THEZE16 March 2009 | AIDS Research and Human Retroviruses, Vol. 11, No. 4Vaccines against RetrovirusesMolecular Characterization of Variable Heavy and Light Chain Regions of Five HIV Type 1-Specific Human Monoclonal Antibodies* ERIC M.M. van der DONK, MARTIN SCHUTTEN, ALBERT D.M.E. OSTERHAUS, and ROGER W.J. van der HEIJDEN16 March 2009 | AIDS Research and Human Retroviruses, Vol. 10, No. 12Structural characterization of broadly neutralizing human monoclonal antibodies against the CD4 binding site of HIV-1 gp120Molecular Immunology, Vol. 31, No. 15Synergistic neutralization of human immunodeficiency virus type 1 by combinations of human monoclonal antibodiesJournal of Virology, Vol. 68, No. 6Multiepitope Polypeptide of the HIV-1 Envelope Induces Neutralizing Monoclonal Antibodies against V3 Loop CARLOS A. DUARTE, MARINIEVE MONTERO, ALINA SERALENA, RODOLFO VALDÉS, VICTOR JIMÉNEZ, JESÚS BENÍTEZ, EMILIO NARCIANDI, JOEL MADRAZO, GABRIEL PADRÓN, GISELLE SÁNCHEZ, GUSTAV GILLJAN, KRISTINA PERSSON, SUANY OJEDA, ABEL CABALLERO, ALINA MIRANDA, MARIA DEL CARMEN DOMÍNGUEZ, BRITTA WAHREN, and ALFREDO MENÉNDEZ16 March 2009 | AIDS Research and Human Retroviruses, Vol. 10, No. 3Cross-Reactivity between Autoimmune Anti-Ul snRNP Antibodies and Neutralizing Epitopes of HIV-1 gp 120/41 ANGELINE DOUVAS and YOSHI TAKEHANA16 March 2009 | AIDS Research and Human Retroviruses, Vol. 10, No. 3Genetically Engineered Human Immunodeficiency Virus Type 1 (HIV-1) VaccinesEnvelope Sequence Variation, Neutralizing Antibodies, and Primate Lentivirus PersistenceA Potent, Neutralizing Human Monoclonal Antibody against a Unique Epitope Overlapping the CD4-Binding Site of HIV-1 gp120 That Is Broadly Conserved across North American and African Virus Isolates ABRAHAM PINTER, WILLIAM J. HONNEN, MARY E. RACHO, and SHERMAINE A. TILLEY16 March 2009 | AIDS Research and Human Retroviruses, Vol. 9, No. 10Diversity of V3 Region Sequences of Human Immunodeficiency Viruses Type 1 from the Central African Republic ELLEN MURPHY, BETTE KORBER, MARIE-CLAUDE GEORGES-COURBOT, BRUNO YOU, ABRAHAM PINTER, DEBRA COOK, MARIE-PAULE KIENY, ALAIN GEORGES, CHRISTIAN MATHIOT, FRANCOISE BARRÉ-SINOUSSI, and MARC GIRARD16 March 2009 | AIDS Research and Human Retroviruses, Vol. 9, No. 10The HIV gp120-CD4 interaction: A target for pharmacological or immunological intervention?Perspectives in Drug Discovery and Design, Vol. 1, No. 1Synergistic Inhibition of HIV-1 Envelope-Mediated Cell Fusion by CD4-Based Molecules in Combination with Antibodies to gp120 or gp41 GRAHAM P. ALLAWAY, ANDREW M. RYDER, GARY A. BEAUDRY, and PAUL J. MADDON16 March 2009 | AIDS Research and Human Retroviruses, Vol. 9, No. 7Characterization of conserved human immunodeficiency virus type 1 gp120 neutralization epitopes exposed upon gp120-CD4 bindingJournal of Virology, Vol. 67, No. 7Maternal Transmission of the Human Immunodeficiency Virus: Can It Be Prevented? TIMOTHY W. BABA, JONE E. SAMPSON, CANDIDA FRATAZZI, MICHAEL F. GREENE, and RUTH M. RUPRECHT12 June 2009 | Journal of Women's Health, Vol. 2, No. 3Cellular Receptors and Viral Glycoproteins Involved in Retrovirus EntryHuman Immunodeficiency Virus VaccinesSynergistic interaction between ligands binding to the CD4 binding site and V3 domain of human immunodeficiency virus type I gpl20Virology, Vol. 191, No. 2Production of Human Monoclonal Antibodies Specific for Conformational and Linear Non-V3 Epitopes of gp120 S. KARWOWSKA, M.K. GORNY, A. BUCHBINDER, V. GIANAKAKOS, C. WILLIAMS, T. FUERST, and S. ZOLLA-PAZNER16 March 2009 | AIDS Research and Human Retroviruses, Vol. 8, No. 6Development of a vaccine for the prevention of AIDS, a critical appraisalVaccine, Vol. 10, No. 14 Volume 8Issue 4Apr 1992 To cite this article:Aby Buchbinder, Sylwia Karwowska, Miroslaw K. Gorny, Sherri T. Burda, and Susan Zolla-Pazner.Synergy Between Human Monoclonal Antibodies to HIV Extends Their Effective Biologic Activity Against Homologous and Divergent Strains.AIDS Research and Human Retroviruses.Apr 1992.425-427.http://doi.org/10.1089/aid.1992.8.425Published in Volume: 8 Issue 4: March 16, 2009PDF download